Paula Mussnich
Overview
Explore the profile of Paula Mussnich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAngelo D, Mussnich P, Sepe R, Raia M, Del Vecchio L, Cappabianca P, et al.
J Mol Med (Berl)
. 2019 May;
97(7):1019-1032.
PMID: 31076808
Long non-coding RNAs (lncRNAs) are emerging as fundamental players in cancer biology. Indeed, they are deregulated in several neoplasias and have been associated with cancer progression, tumor recurrence, and resistance...
2.
DAngelo D, Mussnich P, Arra C, Battista S, Fusco A
J Mol Med (Berl)
. 2017 Mar;
95(4):353-360.
PMID: 28293697
The high-mobility group A (HMGA) proteins are frequently overexpressed in human malignancies and correlate with the presence of metastases and reduced patient survival. Here, we highlight the main studies evidencing...
3.
Mussnich P, Raverot G, Jaffrain-Rea M, Fraggetta F, Wierinckx A, Trouillas J, et al.
Cell Cycle
. 2015 Jul;
14(16):2590-7.
PMID: 26125663
MicroRNAs (miRNAs) are small noncoding RNAs that act as posttranscriptional regulators of gene expression, and are frequently altered in human neoplasias. Here, we have analyzed the miRNA expression profile of...
4.
Mussnich P, Rosa R, Bianco R, Fusco A, DAngelo D
Expert Opin Ther Targets
. 2015 Jun;
19(8):1017-26.
PMID: 26107137
Objectives: We aimed to analyze the differentially-expressed miRNAs in colon cancer cells in order to identify novel potential biomarkers involved in cancer cell resistance. Design And Methods: We investigated the...
5.
Esposito F, De Martino M, DAngelo D, Mussnich P, Raverot G, Jaffrain-Rea M, et al.
Cell Cycle
. 2015 Apr;
14(9):1471-5.
PMID: 25894544
Numerous studies have established that High Mobility Group A (HMGA) proteins play a pivotal role on the onset of human pituitary tumors. They are overexpressed in pituitary tumors, and, consistently,...
6.
DAngelo D, Mussnich P, Rosa R, Bianco R, Tortora G, Fusco A
BMC Cancer
. 2014 Nov;
14:851.
PMID: 25409711
Background: Development of resistance to conventional drugs and novel biological agents often impair long-term chemotherapy. HMGA gene overexpression is often associated with antineoplastic drug resistance and reduced survival. Inhibition of...
7.
Leone V, Langella C, DAngelo D, Mussnich P, Wierinckx A, Terracciano L, et al.
Mol Cell Endocrinol
. 2014 Apr;
390(1-2):1-7.
PMID: 24681352
MicroRNA (miRNA) deregulation plays a critical role in tumorigenesis. miR-23b and miR-130b are induced by thyrotropin in thyroid cells in a cAMP-dependent manner. The aim of our work has been...
8.
Mussnich P, DAngelo D, Leone V, Croce C, Fusco A
Mol Oncol
. 2013 Feb;
7(3):531-42.
PMID: 23384558
The overexpression of the HMGA1 proteins is a feature of human malignant neoplasias and has a causal role in cell transformation. The aim of our study has been to investigate...
9.
DAngelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, et al.
J Clin Endocrinol Metab
. 2012 May;
97(7):E1128-38.
PMID: 22564666
Context: MicroRNA (miRNA) are an important class of regulators of gene expression. Altered miRNA expression has been constantly found in human neoplasias and plays an important role in the process...